Drugs / Huperzine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00963846 | Mar 2010 → Dec 2012 | schizophrenia | Biomedisyn Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huperzine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00963846 ↗ |